BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/15/2024 6:59:58 AM | Browse: 26 | Download: 0
Category |
Oncology |
Manuscript Type |
Clinical and Translational Research |
Article Title |
Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jian Zhang, Hao Liu, Hang Yu and Wei-xiang Xu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Zhejiang Provincial Science and Technology Program |
2023C03172 |
|
Corresponding Author |
Jian Zhang, MD, Chief, Chief Doctor, Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 1367 West Wenyi Road, Yuhang District, Hangzhou 310003, Zhejiang Province, China. ljzju001@126.com |
Key Words |
Stage classification; Prognosis; Esophagogastric junction cancer; Neoadjuvant chemotherapy; Siewert type |
Core Tip |
So far, the ideal staging classification for Siewert II AEG treated with neoadjuvant chemotherapy is lacking. Thus, we established nomogram based on the Cox regression model which incorporating variables associated with overall survival (OS) and disease-specific survival (DSS). The novel nomogram model showed the best performance compared with 8th American Joint Committee of Cancer pathological staging schemes of esophagus cancer and gastric cancer. The time-receiver operating characteristic curve of the novel nomogram showed an excellent predictive value in terms of 5-year OS [0.665 (0.626-0.704)] and 5-year DSS [0.675 (0.636-0.713)]. Finally, a friendly online web application was developed for clinical use. |
Citation |
Zhang J, Liu H, Yu H, Xu WX. Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy. World J Gastrointest Oncol 2024; In press |
|
Received |
|
2023-10-21 09:03 |
|
Peer-Review Started |
|
2023-10-21 09:04 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-31 07:16 |
|
Revised |
|
2024-03-09 09:12 |
|
Second Decision |
|
2024-04-15 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-04-15 06:59 |
|
Articles in Press |
|
2024-04-15 06:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345